http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102787174-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602adeb44fa02ec265ca31e708bc6ca2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b18c01a5fc82a8b020f5c03e93820678 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3429d447ec25179b5d6445b609c65f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4690a53d04813990f099a77e7a9db995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b9433e06598ab2754ffc154faa88d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f36d92562b2c70a596bc08f65030f12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1c7c0ffed070ec039664945057d423e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc7552ccc7a15ba0b532dce0669467f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbe6e767d072c02f6f376beaf739eb41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_657f2f350f7d6eb91bfdb01502918cfa |
| publicationDate | 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102787174-B |
| titleOfInvention | Kit for morbidity-related tumor suppressor gene epigenetic mutation detection of gastrointestinal neoplasms and application thereof |
| abstract | The invention relates to a kit for morbidity-related tumor suppressor gene epigenetic mutation detection of gastrointestinal neoplasms and application thereof. The kit mainly comprises 25 pairs of gastrointestinal neoplasm morbidity-related tumor suppressor gene promotor region CpG-island amplification and sequencing primers of 9 kinds and a polymerase chain reaction (PCR) amplification reagent. Through a PCR amplification product obtained through the kit, a gene CpG-island methylation state can be analyzed through the methods of methylation specific PCR (MSP), combined bisulphite-restrictionanalysis (COBRA) or bisulfite sequencing PCR (BSP) and the like. The kit has the efficient effect of detecting CpG-island methylation and is used for the morbidity-related tumor suppressor gene epigenetic mutation detection of the gastrointestinal neoplasms. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105969896-A |
| priorityDate | 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.